Rose Gonzales
Parter, Thames Pharma Partners, LLC
Rose Gonzales is listed as Parter, Thames Pharma Partners, LLC. Rose is scheduled to speak at SLAS 2027 International Conference & Exhibition on 30 January 2027.
Compiled from published conference agendas; not yet confirmed by Rose. Is this you? Claim this profile.
About
Rose Gonzales is a Partner at Thames Pharma Partners, bringing over two decades of expertise in early drug discovery technologies, laboratory automation, HTS, and sample management. A recognized industry leader and SLAS Fellow, she specializes in compound management, high throughput screening, assay development, project management, and clinical supply logistics. Throughout her career, she has guided high-performing teams at major pharmaceutical companies, including Pfizer, Merck, Pharmacia & Upjohn, and Procter & Gamble. Notably, during her tenure at Pfizer, she received the R&D Achievement Award for her leadership in developing and implementing the company’s industry-leading Hit-ID infrastructure. Rose holds a doctorate in Chemical Engineering.
Upcoming
SLAS 2027 International Conference & Exhibition 30 January 2027 – 3 February 2027
- Building Resilient Labs: Improving Scalability and Adaptability Across the Lab Value Chain Speaker · 30 January 2027
Spoke alongside
People who have shared a session with Rose at events on B2DB.
- David Dambman Co-Founder · Lab Sync Inc. 1 shared session
- David Jennions VP of Development · GRAIL, Inc. 1 shared session
- Thomas Frech Lab Innovation Coach · Independent 1 shared session